FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311022721> ?p ?o ?g. }

• W4311022721 endingPage "130" @default.
• W4311022721 startingPage "123" @default.
• W4311022721 abstract "Abstract Background Clinical trials of HER2-directed therapy that omit neoadjuvant conventional chemotherapy for HER+ breast cancer demonstrate that a subset of patients still obtains a pCR. Identifying tumor characteristics which predict pCR may help select patients for de-escalated neoadjuvant dual HER2-targeted treatment without chemotherapy. This is the first study evaluating the HER2/CEP17 ratio by FISH as a biomarker to predict pCR among patients who received neoadjuvant anti-HER2 regimens without chemotherapy. Patients and Methods Data from patients with locally advanced HER2+ breast cancer who received neoadjuvant dual HER2-targeted therapy without conventional chemotherapy from a single center was retrospectively reviewed. All patients were enrolled in one of 3 clinical trials evaluating chemotherapy de-escalation. Logistic regression modeling assessed for a relationship between the HER2/CEP17 FISH ratio obtained from baseline tissue biopsy and pCR based on pathology at the time of definitive breast surgery following neoadjuvant treatment. Results Following neoadjuvant treatment with dual HER2-targeted therapies in 56 patients, the probability of pCR was 73% among patients with a HER2 ratio of 13.1 compared to a probability of 38% among patients with HER2 ratio of 5.5 (OR 4.14, 95% CI 1.44-11.89; P = .012). This positive association persisted after controlling for different treatment regimens administered (OR 2.87, 95% CI 0.9-9.18, P = .020). Conclusions These data found a positive association between the HER2/CEP17 FISH ratio and pCR following neoadjuvant dual HER2-targeted therapy without chemotherapy. Larger prospective studies are needed to validate the HER2 ratio as a biomarker to select patients for neoadjuvant dual anti-HER2 therapy without chemotherapy." @default.
• W4311022721 created "2022-12-22" @default.
• W4311022721 creator A5005937218 @default.
• W4311022721 creator A5013004380 @default.
• W4311022721 creator A5051298255 @default.
• W4311022721 creator A5062656698 @default.
• W4311022721 creator A5071841968 @default.
• W4311022721 creator A5073703969 @default.
• W4311022721 creator A5075889627 @default.
• W4311022721 date "2022-12-10" @default.
• W4311022721 modified "2023-10-06" @default.
• W4311022721 title "Using the <i>HER2/CEP17</i> FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer" @default.
• W4311022721 cites W1811689 @default.
• W4311022721 cites W1923236865 @default.
• W4311022721 cites W1987326983 @default.
• W4311022721 cites W2000798782 @default.
• W4311022721 cites W2025644430 @default.
• W4311022721 cites W2075894019 @default.
• W4311022721 cites W2093274439 @default.
• W4311022721 cites W2094793616 @default.
• W4311022721 cites W2101979288 @default.
• W4311022721 cites W2110444464 @default.
• W4311022721 cites W2123591186 @default.
• W4311022721 cites W2137228442 @default.
• W4311022721 cites W2141393790 @default.
• W4311022721 cites W2147299492 @default.
• W4311022721 cites W2147415463 @default.
• W4311022721 cites W2159967578 @default.
• W4311022721 cites W2167587342 @default.
• W4311022721 cites W2220484928 @default.
• W4311022721 cites W2318605753 @default.
• W4311022721 cites W2494995001 @default.
• W4311022721 cites W2585180563 @default.
• W4311022721 cites W2590177834 @default.
• W4311022721 cites W2591481727 @default.
• W4311022721 cites W2727635070 @default.
• W4311022721 cites W2789034017 @default.
• W4311022721 cites W2791335228 @default.
• W4311022721 cites W2914243257 @default.
• W4311022721 cites W2930274452 @default.
• W4311022721 cites W2942862617 @default.
• W4311022721 cites W2982414110 @default.
• W4311022721 cites W2996055214 @default.
• W4311022721 cites W2996630100 @default.
• W4311022721 cites W3006134372 @default.
• W4311022721 cites W3157823694 @default.
• W4311022721 doi "https://doi.org/10.1093/oncolo/oyac247" @default.
• W4311022721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36495309" @default.
• W4311022721 hasPublicationYear "2022" @default.
• W4311022721 type Work @default.
• W4311022721 citedByCount "0" @default.
• W4311022721 crossrefType "journal-article" @default.
• W4311022721 hasAuthorship W4311022721A5005937218 @default.
• W4311022721 hasAuthorship W4311022721A5013004380 @default.
• W4311022721 hasAuthorship W4311022721A5051298255 @default.
• W4311022721 hasAuthorship W4311022721A5062656698 @default.
• W4311022721 hasAuthorship W4311022721A5071841968 @default.
• W4311022721 hasAuthorship W4311022721A5073703969 @default.
• W4311022721 hasAuthorship W4311022721A5075889627 @default.
• W4311022721 hasBestOaLocation W43110227211 @default.
• W4311022721 hasConcept C121608353 @default.
• W4311022721 hasConcept C126322002 @default.
• W4311022721 hasConcept C143998085 @default.
• W4311022721 hasConcept C151956035 @default.
• W4311022721 hasConcept C2776694085 @default.
• W4311022721 hasConcept C2778292576 @default.
• W4311022721 hasConcept C2779786085 @default.
• W4311022721 hasConcept C2781230642 @default.
• W4311022721 hasConcept C530470458 @default.
• W4311022721 hasConcept C71924100 @default.
• W4311022721 hasConceptScore W4311022721C121608353 @default.
• W4311022721 hasConceptScore W4311022721C126322002 @default.
• W4311022721 hasConceptScore W4311022721C143998085 @default.
• W4311022721 hasConceptScore W4311022721C151956035 @default.
• W4311022721 hasConceptScore W4311022721C2776694085 @default.
• W4311022721 hasConceptScore W4311022721C2778292576 @default.
• W4311022721 hasConceptScore W4311022721C2779786085 @default.
• W4311022721 hasConceptScore W4311022721C2781230642 @default.
• W4311022721 hasConceptScore W4311022721C530470458 @default.
• W4311022721 hasConceptScore W4311022721C71924100 @default.
• W4311022721 hasIssue "2" @default.
• W4311022721 hasLocation W43110227211 @default.
• W4311022721 hasLocation W43110227212 @default.
• W4311022721 hasLocation W43110227213 @default.
• W4311022721 hasOpenAccess W4311022721 @default.
• W4311022721 hasPrimaryLocation W43110227211 @default.
• W4311022721 hasRelatedWork W1255356622 @default.
• W4311022721 hasRelatedWork W1722328147 @default.
• W4311022721 hasRelatedWork W2013223170 @default.
• W4311022721 hasRelatedWork W2066747782 @default.
• W4311022721 hasRelatedWork W2316766300 @default.
• W4311022721 hasRelatedWork W2367105124 @default.
• W4311022721 hasRelatedWork W3089077900 @default.
• W4311022721 hasRelatedWork W3092055942 @default.
• W4311022721 hasRelatedWork W4322772378 @default.
• W4311022721 hasRelatedWork W812572266 @default.
• W4311022721 hasVolume "28" @default.
• W4311022721 isParatext "false" @default.

• next